Published September 26, 2018 (News release from Future Science Group)
A survey of the Canadian direct-to-consumer marketplace reveals 30 Canadian businesses advertise unproven stem cell therapies at 43 clinics in Ontario, British Columbia, Alberta, Quebec, Nova Scotia and Saskatchewan. The most commonly marketed therapies are for orthopedic and musculoskeletal conditions, pain relief, and sports-related injuries, but one B.C. company markets treatments for ALS, Parkinson’s disease, stroke, multiple sclerosis, scleroderma, muscular dystrophy, post myocardial infarction and erectile dysfunction. With lack of regulatory or disciplinary action by Health Canada or professional regulators, the researchers warn that the number of companies advertising questionable stem cell therapy will likely increase.
Canadian author: Leigh Turner, University of Minnesota – firstname.lastname@example.org
Canadian clinics market unproven stem cell treatments
Marketing stem cell therapies | Ancient sick care | Pulsar cools its jet | SMCC Heads Up Embargoed and recently published research with a Canadian focus, curated by SMCC for science journalists. R...Read more
Nature Published September 26, 2018 Researchers report an evolving jet launched by a strongly magnetized, accreting neutron star. The jet’s radio luminosity is two orders of magnitude fainter tha...Read more